Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice

Gayoso-Rey, M; Diaz-Trastoy, O; Romero-Ventosa, EY; Garcia-Beloso, N; Gonzalez-Freire, L; Lorenzo-Lorenzo, K; Mantinan-Gil, B; Palmeiro-Carballeira, R; Bravo-Amaro, M; Lopez-Gil-Otero, MD; Martinez-Reglero, C; Crespo-Diz, C; Fernandez-Catalina, P; Corrales, GP

Gayoso-Rey, M (corresponding author), Complejo Hosp Univ Vigo, Hosp Pharm Serv, Camino Canotais 44, Vigo 36204, Spain.

CLINICAL THERAPEUTICS, 2021; 43 (4): E111

Abstract

Purpose: To evaluate the effectiveness, adverse reactions, and adherence to treatment of hypolipidemic inhibitors of proprotein convertase subtilisin/......

Full Text Link